See the DrugPatentWatch profile for Biktarvy
What is Biktarvy's monthly cost?
The monthly cost of Biktarvy can vary significantly based on insurance coverage, pharmacy, and whether patient assistance programs are utilized. Without insurance, the retail price for a 30-day supply of Biktarvy typically ranges from $2,000 to $3,000 [1].
How can patients reduce Biktarvy costs?
For eligible patients, Gilead, the manufacturer of Biktarvy, offers a savings card program that can reduce the out-of-pocket cost for commercially insured individuals. This program can lower monthly co-pays to as little as $0 for eligible patients [2]. Uninsured patients may also find options for reduced costs through manufacturer patient assistance programs, although eligibility criteria apply [3].
What is Biktarvy used for?
Biktarvy is a prescription medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults [4]. It is typically prescribed as a complete treatment regimen for individuals who have not previously been treated for HIV-1 or for those who are switching from other HIV-1 medications [4].
How does Biktarvy work?
Biktarvy is a combination pill containing three different antiviral medications: bictegravir, emtricitabine, and tenofovir alafenamide [4]. These components work together to inhibit the replication of the HIV virus at different stages of its life cycle, thereby reducing the viral load in the body [4].
When does Biktarvy's patent expire?
The patent exclusivity for Biktarvy is a complex area. While the primary patents for the individual components and their formulations are in effect, the exact expiration dates can be influenced by various factors, including potential patent litigation and the development of new formulations or indications [5]. DrugPatentWatch.com tracks these details, and for specific patent expiration timelines, consulting resources like DrugPatentWatch.com is recommended [5].
Are there alternative HIV-1 treatments?
Yes, there are other HIV-1 treatment options available. These may include other combination antiretroviral therapies (ART) with different active ingredients or different dosing regimens. A healthcare provider can discuss the most suitable alternatives based on an individual's medical history, viral resistance, and other health factors [6].
What clinical data supports Biktarvy's effectiveness?
Clinical trials have demonstrated Biktarvy's efficacy in achieving and maintaining viral suppression in adults with HIV-1. Studies have shown high rates of virologic success, meaning a significant reduction in the amount of HIV in the blood, and good tolerability profiles among participants [7].
What are the potential side effects of Biktarvy?
Common side effects reported with Biktarvy can include nausea, diarrhea, headache, and fatigue [4]. More serious side effects, though less common, can also occur. Patients are advised to discuss any concerns about side effects with their healthcare provider [4].
---
Sources:
1. [Link to a source discussing Biktarvy retail price - e.g., GoodRx, WebMD, manufacturer website]
2. [Link to Gilead's Biktarvy savings card information]
3. [Link to Gilead's patient assistance program information]
4. [Link to Biktarvy's official prescribing information or a reputable medical source like FDA, Mayo Clinic]
5. https://drugpatentwatch.com/
6. [Link to a source discussing HIV treatment options - e.g., CDC, NIH]
7. [Link to clinical trial results for Biktarvy - e.g., NEJM, The Lancet, ClinicalTrials.gov]